Timothy Van Hauwermeiren

Timothy Van Hauwermeiren discloses dealings in 2 companies, chiefly Denali Therapeutics Inc. and iTeos Therapeutics, Inc. The record holds 3 filings, for trades running from 13 May 2025 to 3 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 5 June 2026: a share grant, in Denali Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.